Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality?

Chau I, Cunningham D.

N Engl J Med. 2002 Apr 4;346(14):1085-7. No abstract available.

PMID:
11932478
2.

Cyclooxygenase-2 and colorectal cancer.

DuBois RN.

Prog Exp Tumor Res. 2003;37:124-37. Review. No abstract available.

PMID:
12795052
3.

[Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].

Florent C, Meary N.

Bull Cancer. 2004 May;91 Spec No:S85-8. Review. French.

PMID:
15239335
4.

COX-2 inhibition and colorectal cancer.

Koehne CH, Dubois RN.

Semin Oncol. 2004 Apr;31(2 Suppl 7):12-21. Review.

PMID:
15252926
5.

Aspirin use and potential mechanisms for colorectal cancer prevention.

Williams CS, Smalley W, DuBois RN.

J Clin Invest. 1997 Sep 15;100(6):1325-9. Review. No abstract available.

6.

Anti-inflammatories for cardiovascular disease.

Masferrer JL, Needleman P.

Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12400-1. Review. No abstract available.

7.

New avenues for the prevention of colorectal cancer: targeting cyclo-oxygenase-2 activity.

Gupta RA, DuBois RN, Wallace MC.

Best Pract Res Clin Gastroenterol. 2002 Dec;16(6):945-56. Review.

PMID:
12473300
8.

An update on specific COX-2 inhibitors: the COXIBs.

Gupta S, Crofford LJ.

Bull Rheum Dis. 2001;50(1):1-4. Review. No abstract available.

PMID:
12092091
9.

The coxibs, selective inhibitors of cyclooxygenase-2.

FitzGerald GA, Patrono C.

N Engl J Med. 2001 Aug 9;345(6):433-42. Review. No abstract available.

PMID:
11496855
10.

[Specific inhibitors of cyclooxygenase type 2] ].

Tomasová-Studýnková J.

Vnitr Lek. 2002 May;48(5):403-8. Review. Czech.

PMID:
12061207
11.

Chemoprevention strategies using NSAIDs and COX-2 inhibitors.

Keller JJ, Giardiello FM.

Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S140-9. Review.

PMID:
14508092
12.

[Therapeutic advances with coxibs: few certainties and a lot of doubts].

Jouzeau JY, Daouphars M, Netter P.

Therapie. 2004 Mar-Apr;59(2):207-11. Review. French. No abstract available.

PMID:
15359614
13.

[Current post-marketing information. Effects and adverse effects of celecoxib].

Schmidt H, Geisslinger G.

Pharm Unserer Zeit. 2002;31(2):180-7. Review. German. No abstract available.

PMID:
11977454
14.

[New anti-inflammatory analgetics--are they needed?].

Paakkari I.

Duodecim. 1999;115(20):2217-24. Review. Finnish. No abstract available.

PMID:
11973925
15.

COX-2 inhibitors. Are they nonsteroidal anti-inflammatory drugs with a better safety profile?

Simon LS.

Gastroenterol Clin North Am. 2001 Dec;30(4):1011-25, viii. Review.

PMID:
11764530
16.

Efficacy of cyclooxygenase-2-specific inhibitors.

Cannon GW, Breedveld FC.

Am J Med. 2001 Feb 19;110 Suppl 3A:6S-12S. Review.

PMID:
11173044
17.

Celecoxib: a new option in the treatment of arthropathies and familial adenomatous polyposis.

Davies NM, Gudde TW, de Leeuw MA.

Expert Opin Pharmacother. 2001 Jan;2(1):139-52. Review.

PMID:
11336575
18.

COX-2--selective NSAIDs.

Hutchison R.

Am J Nurs. 2004 Mar;104(3):52-5; quiz 55-6. Review. No abstract available. Erratum in: Am J Nurs. 2004 May;104(5):16.

PMID:
15108571
19.

[Chemoprevention of familial cancer].

Ishikawa H.

Gan To Kagaku Ryoho. 1997 Jun;24(8):951-7. Review. Japanese.

PMID:
9212803
20.

[New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].

Oliw E, Wollheim FA.

Lakartidningen. 2000 Jun 14;97(24):2942-4. Review. Swedish. No abstract available.

PMID:
10900877

Supplemental Content

Support Center